FNBT
PDLI

FineMark National Bank & Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

FineMark National Bank & Trust’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,500
Closed -$102K – 1519
2015
Q1 		$102K Buy
+14,500
New +$105K 0.01% 485

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FineMark National Bank & Trust's PDLI Position: Q2 2015 in Review

FineMark National Bank & Trust sold out of PDL BioPharma, Inc. (PDLI) in Q2 2015, closing a stake of 14,500 shares — an estimated $102K sold.

FineMark National Bank & Trust first reported a position in PDLI in Q1 2015 and held it in 1 quarter. The position peaked at $102K in Q1 2015. 204 funds tracked by Wall St. Rank hold PDLI as of Q2 2015.

  • FineMark National Bank & Trust reported no remaining PDL BioPharma, Inc. position as of Q2 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 14,500 PDL BioPharma, Inc. shares in Q2 2015, an estimated $102K.
  • FineMark National Bank & Trust first reported a position in PDL BioPharma, Inc. in Q1 2015 and held it in 1 quarter.
  • FineMark National Bank & Trust's PDL BioPharma, Inc. position peaked at $102K in Q1 2015.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2015.

Based on FineMark National Bank & Trust's 13F filing for Q2 2015, filed 11 Aug 2015.